Bailard’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-19,131
Closed -$173K 839
2024
Q3
$173K Hold
19,131
﹤0.01% 717
2024
Q2
$203K Sell
19,131
-8,166
-30% -$87K 0.01% 685
2024
Q1
$240K Buy
+27,297
New +$222K 0.01% 639
2021
Q3
Sell
-34,665
Closed -$290K 766
2021
Q2
$290K Buy
34,665
+2,300
+7% +$19.8K 0.01% 547
2021
Q1
$268K Buy
32,365
+7,800
+32% +$55.3K 0.01% 556
2020
Q4
$159K Buy
+24,565
New +$155K 0.01% 608
2018
Q1
Sell
-31,037
Closed -$203K 510
2017
Q4
$203K Buy
+31,037
New +$208K 0.01% 422
2016
Q1
Sell
-16,400
Closed -$106K 350
2015
Q4
$106K Buy
+16,400
New +$108K 0.05% 200

Other funds holding ULBI

Bailard's ULBI Position: Q4 2024 in Review

Bailard sold out of Ultralife (ULBI) in Q4 2024, closing a stake of 19,131 shares — an estimated $173K sold.

Bailard first reported a position in ULBI in Q4 2015 and held it in 8 quarters. The position peaked at $290K in Q2 2021. 67 funds tracked by Wall St. Rank hold ULBI as of Q4 2024.

  • Bailard reported no remaining Ultralife position as of Q4 2024 after selling out during the quarter.
  • Bailard sold 19,131 Ultralife shares in Q4 2024, an estimated $173K.
  • Bailard first reported a position in Ultralife in Q4 2015 and held it in 8 quarters.
  • Bailard's Ultralife position peaked at $290K in Q2 2021.
  • 67 funds tracked by Wall St. Rank held Ultralife as of Q4 2024.

Based on Bailard's 13F filing for Q4 2024, filed 5 Feb 2025.